Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|October 29, 2014
[Metastasis in testis from prostate cancer]Mike Allan Mortensen, Birte Engvad, Louise Geertsen, et al.
BMC Research Notes|May 21, 2022
Introduction of salvage prostatectomy in Denmark: the initial experienceMike Allan Mortensen, Charlotte Aaberg Poulsen, Göran Ahlgren, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|June 6, 2023
Medical Students Cannot Assess Robotic Surgeons Performing Radical ProstatectomyRikke Groth Olsen, Lars Konge, Khalilullah Hayatzaki, et al.
Research and Reports in Urology|August 24, 2019
Does therapy of the primary tumor matter in oligometastatic prostate cancer? A prospective 10-year follow-up studyMads Hvid Poulsen, Jørn Skibsted Jakobsen, Mike Allan Mortensen, et al.
Prostate International|September 6, 2019
18F-Fluoromethylcholine-positron emission tomography/computed tomography for diagnosing bone and lymph node metastases in patients with intermediate- or high-risk prostate cancerMike Allan Mortensen, Mads Hvid Poulsen, Oke Gerke, et al.
BMC Research Notes|December 12, 2018
A prospective study on dual time 18F-FDG-PET/CT in high-risk prostate cancer patientsMike Allan Mortensen, Mie Holm Vilstrup, Mads Hvid Poulsen, et al.
World Journal of Urology|October 26, 2023
Laypersons versus experienced surgeons in assessing simulated robot-assisted radical prostatectomyRikke Groth Olsen, Lars Konge, Khalilullah Hayatzaki, et al.
Scandinavian Journal of Urology|July 2, 2020
A prospective study of a urine and plasma biomarker test for the prediction of gleason ≥3 + 4 prostate cancer in a mixed cohortMads Hvid Poulsen, Søren Feddersen, Maher Albitar, et al.
Clinical Physiology and Functional Imaging|September 25, 2020
Artificial intelligence-based detection of lymph node metastases by PET/CT predicts prostate cancer-specific survivalPablo Borrelli, Måns Larsson, Johannes Ulén, et al.
Cancers|May 13, 2026
The Prognostic Value of Proclarix in Prostate Cancer Patients Under Active Surveillance: Predicting Transition to Active Treatment and Disease Progression in a Danish CohortAlcibiade Athanasiou, Torben F Hansen, Jonna S Madsen, et al.
Pageof 1